Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sheldon, J.
Right arrow Articles by Goubau, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheldon, J.
Right arrow Articles by Goubau, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1443-1445
© 2000 European Renal Association-European Dialysis and Transplant Association

Human herpes virus 8 infection in kidney transplant patients in Belgium

Julie Sheldon1, Stéphanie Henry2, Michel Mourad3, Monique Bodéus2, Jean-Paul Squifflet3, Thomas F. Schulz1 and Patrick Goubau2,

1 Department of Medical Microbiology and Genitourinary Medicine, The University of Liverpool, Liverpool, UK, 2 Department of Virology and 3 Department of Renal Transplantation, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium

Background. Kaposi sarcoma (KS) may arise as a complication of kidney transplantation. In the Saint Luc Teaching Hospital in Brussels, patients of both Belgian and foreign origin are treated. The prevalence of human herpes virus 8 (HHV-8) infection differs in different geographical settings. We wanted to estimate the background infection rate and the risk of infection in our transplant population: a first step towards evaluating the necessity of HHV-8 screening.

Methods. Serum samples were taken from 210 organ donors over a period of 7 years (30 per year) and from 200 kidney recipients from whom two sera were tested, one pre-transplant and the second 6–12 months post-transplant. All sera were screened for HHV-8 by an enzyme-linked immunosorbant assay using recombinant ORF 65 and ORF 73 antigens and an immunofluorescence assay for the latent antigen. Reactive samples were confirmed by western blotting.

Results. Seven donors (3.3%) were positive for HHV-8 antibodies. Of 198 pre-transplant sera available for evaluation, 15 were positive (7.6%). Post-transplantation 18/199 (9%) were positive: four (2.1% of negatives) had a documented seroconversion and one lost the antibodies. No patients developed KS.

Conclusions. A substantial number of kidney transplant patients already had antibodies to HHV-8 at the time of transplantation. A further 2.1% of seronegative patients had seroconversion, which could have been acquired through the transplanted organ (3.3% of donors were positive) or through transfusion.

Keywords: Belgium; human herpes virus type 8; Kaposi sarcoma; kidney graft

Correspondence and offprint requests to: Dr Patrick Goubau, Unité de Virologie, Ecole de Santé Publique 3055, Cliniques Universitaires St Luc, Clos Chapelle-aux-Champs, 30 B-1200 Bruxelles, Belgium.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Bergallo, C. Costa, S. Margio, F. Sidoti, D. Re, G. P. Segoloni, and R. Cavallo
Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region)
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1757 - 1761.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.